By blocking key signal, researchers maintain embryonic stem cells in vital, undifferentiated state

January 13, 2014

In a paper published in this week's Online Early Edition of the Proceedings of the National Academy of Sciences, researchers from the University of California, San Diego School of Medicine identify a key gene receptor and signaling pathway essential to maintaining human embryonic stem cells in an undifferentiated state.

While the ability of human embryonic (hESCs) to become any type of mature cell, from neuron to heart to skin and bone, is indisputably crucial to , no less important is the mechanism needed to maintain hESCs in their pluripotent state until such change is required.

In a paper published in this week's Online Early Edition of PNAS, researchers from the University of California, San Diego School of Medicine identify a key gene receptor and signaling pathway essential to doing just that – maintaining hESCs in an undifferentiated state.

The finding sheds new light upon the fundamental biology of hESCs – with their huge potential as a diverse therapeutic tool – but also suggests a new target for attacking , which likely rely upon the same receptor and pathway to help spur their rampant, unwanted growth.

The research, led by principal investigator Karl Willert, PhD, assistant professor in the Department of Cellular and Molecular Medicine, focuses upon the role of the highly conserved WNT signaling pathway, a large family of genes long recognized as a critical regulator of stem cell self-renewal, and a particular encoded receptor known as frizzled family receptor 7 or FZD7.

"WNT signaling through FZD7 is necessary to maintain hESCs in an undifferentiated state," said Willert. "If we block FZD7 function, thus interfering with the WNT pathway, hESCs exit their undifferentiated and pluripotent state."

The researchers proved this by using an antibody-like protein that binds to FZD7, hindering its function. "Once FZD7 function is blocked with this FZD7-specific compound, hESCs are no longer able to receive the WNT signal essential to maintaining their undifferentiated state."

FZD7 is a so-called "onco-fetal protein," expressed only during embryonic development and by certain human tumors. Other studies have suggested that FZD7 may be a marker for cancer stem cells and play an important role in promoting tumor growth. If so, said Willert, disrupting FZD7 function in cancer cells is likely to interfere with their development and growth just as it does in hESCs.

Willert and colleagues, including co-author Dennis Carson, MD, of the Sanford Consortium for Regenerative Medicine and professor emeritus at UC San Diego, plan to further test their FZD7-blocking compound as a potential cancer treatment.

Explore further: Stem cells: Keeping differentiation in check

More information: The WNT receptor FZD7 is required for maintenance of the pluripotent state in human embryonic stem cells,

Related Stories

Stem cells: Keeping differentiation in check

February 27, 2013

Researchers at the A*STAR Institute of Medical Biology (IMB) have discovered a critical checkpoint protein that controls when human embryonic stem cells (hESCs) begin to differentiate.

Scientists engineer human stem cells

December 6, 2013

In an important scientific breakthrough in regenerative medicine, researchers at A*STAR's Genome Institute of Singapore have successfully converted human embryonic stem cells (hESCs) cultured in the laboratory to a state ...

Recommended for you

Trade in invasive plants is blossoming

October 3, 2015

Every day, hundreds of different plant species—many of them listed as invasive—are traded online worldwide on auction platforms. This exacerbates the problem of uncontrollable biological invasions.

Ancestral background can be determined by fingerprints

September 28, 2015

A proof-of-concept study finds that it is possible to identify an individual's ancestral background based on his or her fingerprint characteristics – a discovery with significant applications for law enforcement and anthropological ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.